undamentalytics Newsletter

Medline Inc. valuation and forecast

Explore the models for Medline Inc., adjust their assumptions and compare your own valuation with the platform's.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Analyst recommendations

27 analysts, Oct 2026
Buy2385%
Hold415%
Sell00%

Monthly trend

  1. Oct 2026716427
  2. Sep 2026716427
  3. Aug 2026716427
  4. Jul 2026716427

Counts of recommendations published by analysts covering Medline Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Price history

Loading chart…

Third-party market data · may be delayed

MDLN valuation questions

How does Fundamentalytics value Medline Inc.?
We use the models that fit Medline Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.

Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Medline Inc.

Compare with peers